P2B001 Study site Syracuse — Syracuse, New York

P2B001 Study site Syracuse is a clinical research site located in Syracuse, New York, United States 13210.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

P2B001 Study site Syracuse has participated in 1 clinical trials.

Therapeutic areas: Parkinson Disease, Early Parkinson's Disease.

Sponsors: Pharma Two B Ltd..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for P2B001 Study site Syracuse?

P2B001 Study site Syracuse has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has P2B001 Study site Syracuse conducted?

P2B001 Study site Syracuse has 1 clinical trials on record. Their work covers Parkinson Disease, Early Parkinson's Disease.

Is P2B001 Study site Syracuse accredited by Crixeo Health?

P2B001 Study site Syracuse has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about P2B001 Study site Syracuse?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.